Emerald Health Sciences Inc. Skye Bioscience, Inc. (SKYE) insider trading activity

SKYE Quotes by TradingView

Emerald Health Sciences Inc. is > 10% Shareholder of Skye Bioscience, Inc.. Currently has a direct ownership of 169 Million shares of SKYE, which is worth approximately $417 Million. The most recent transaction as insider was on Feb 22, 2023, when has been sold 58,020,650 shares (Common Stock) at a price of $0.03 per share, resulting in proceeds of $1,740,619. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 169M
0% 3M change
0% 12M change
Total Value Held $417 Million

Emerald Health Sciences Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2023
BUY
Grant, award, or other acquisition
$1,740,619 $0.03 p/Share
58,020,650 Added 25.51%
169,407,901 Common Stock
EHS

Emerald Health Sciences Inc.

> 10% Shareholder
Vancouver, A1

Track Institutional and Insider Activities on SKYE

Follow Skye Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SKYE shares.

Notify only if

Insider Trading

Get notified when an Skye Bioscience, Inc. insider buys or sells SKYE shares.

Notify only if

News

Receive news related to Skye Bioscience, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SKYE